Dupilumab Subcutaneous and Uceris (Budesonide Extended-Release Tablets)
Determining the interaction of Dupilumab Subcutaneous and Uceris (Budesonide Extended-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: budesonide
Brand name: Entocort EC, Uceris, Pulmicort Flexhaler, Pulmicort Respules
Synonyms: Uceris, Uceris Foam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Uceris (Budesonide Rectal Foam)
- Dupilumab Subcutaneous-Uceris Foam
- Dupilumab Subcutaneous-Uceris Rectal
- Dupilumab Subcutaneous-Uceris Tablets
- Dupilumab Subcutaneous-Udenyca
- Dupilumab Subcutaneous-Ulipristal
- Uceris (Budesonide Extended-Release Tablets)-Dupixent
- Uceris (Budesonide Extended-Release Tablets)-Duplex T Topical
- Uceris (Budesonide Extended-Release Tablets)-Durachol
- Uceris (Budesonide Extended-Release Tablets)-Duraclon
- Uceris (Budesonide Extended-Release Tablets)-Duraclon injection
- Uceris (Budesonide Extended-Release Tablets)-Duraflu